Recruiting

Lung Cancer Screening

Sponsor:

Timothy Mullett

Code:

NCT07639255

Conditions

Lung Cancer Screening

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

QUILS System

Study Details

Brief summary:

This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.

Conditions

Lung Cancer Screening

Study ID

NCT07639255

Start date

Apr 1, 2025

Status verified date

Jun, 2026

Completion date

Jun 1, 2028

Anticipated

Primary completion date

Jun 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Participants in Lung Cancer Screening Program, including physicians, nurses, administrators and other staff responsible for the conduct of the program.
  • Willing to participate in the QUILS Index Assessment Survey process
  • Willing to participate in the QUILS Audit Feedback presentations Willing to participate in formative evaluation interviews

Exclusion Criteria:

  • Unwilling to participate in the QUILS Index Assessment Survey process
  • Unwilling to participate in the QUILS Audit Feedback presentations
  • Unwilling to participate in formative evaluation interviews

Study Design

Enrollment

330 participants

Anticipated

Intervention Model

Single group

Primary purpose

Screening

Interventions and Outcome Measures

Arms

other: QUILS Kentucky Coalition Initative

Interventions

QUILS System

Implementation initiative involving statewide coalition engagement surveys, interviews, educational outreach, and collaborative activities designed to improve awareness, coordination, policy support, and implementation of equitable and high-quality lung screening programs.

Primary outcome measure

  • Change in Quality Improvement Lung Cancer Screening (QUILS) Index Assessment Score [ Time Frame: One year following study start up and initial assessment. ]

Central Contacts and Locations

Central contacts

Locations

King's Daughter's Medical Center

Recruiting

Ashland, Kentucky, United States, 41101

Contacts

Taylor Regional Hospital

Recruiting

Campbellsville, Kentucky, United States, 42718

Contacts

St. Elizabeth Healthcare

Recruiting

Edgewood, Kentucky, United States, 41017

Contacts

Georgetown Cancer Treatment Cancer

Recruiting

Georgetown, Kentucky, United States, 40324

Contacts

TJ Samson Community Hospital

Recruiting

Glasgow, Kentucky, United States, 42141

Contacts

Hazard Appalachian Regional Healthcare Medical Center

Recruiting

Hazard, Kentucky, United States, 41701

Contacts

Lexington VA Health Care System

Recruiting

Lexington, Kentucky, United States, 40502

Contacts

St. Joseph Health (Catholic Health Initiatives)

Recruiting

Lexington, Kentucky, United States, 40504

Contacts

University of Kentucky Markey Cancer Center

Recruiting

Lexington, Kentucky, United States, 40536

Contacts

The James Graham Brown Cancer Center at University of Louisville

Recruiting

Louisville, Kentucky, United States, 40202

Contacts

Meadowview Regional Medical Center

Recruiting

Maysville, Kentucky, United States, 41056

Contacts

Saint Claire Regional Medical Center

Recruiting

Morehead, Kentucky, United States, 40351

Contacts

Rockcastle Regional Hospital

Recruiting

Mount Vernon, Kentucky, United States, 40456

Contacts

Owensboro Health Mitchell Memorial Cancer Center

Recruiting

Owensboro, Kentucky, United States, 42303

Contacts

Mercy Health - Paducah Cancer Center

Recruiting

Paducah, Kentucky, United States, 42003

Contacts

Lake Cumberland Regional Hospital

Recruiting

Somerset, Kentucky, United States, 42501

Contacts

Clark Regional Medical Center

Recruiting

Winchester, Kentucky, United States, 40391

Contacts

More Information

Sponsor

Timothy Mullett

Last update posted

Jul 1, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Timothy Mullett on 2026-07-01.